-
1
-
-
0026055728
-
Chemotherapy in advanced ovarian cancer: An overview of randomised clinical trials
-
Advanced Ovarian Cancer Trialists Group. Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Br Med Journal 1991; 303: 884-93.
-
(1991)
Br Med Journal
, vol.303
, pp. 884-893
-
-
-
2
-
-
0026009503
-
Long Term Survival in Ovarian Cancer: Mature Data from the Netherlands Joint Study Group for Ovarian Cancer
-
Neijt JP, ten Bokkel Huinink WW, van der Burg MEL et al. Long Term Survival in Ovarian Cancer: Mature Data from The Netherlands Joint Study Group for Ovarian Cancer. Eur J Cancer 1991; 27: 1367-72.
-
(1991)
Eur J Cancer
, vol.27
, pp. 1367-1372
-
-
Neijt, J.P.1
Ten Bokkel Huinink, W.W.2
Van Der Burg, M.E.L.3
-
3
-
-
0030054309
-
Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
-
McGuire WP, Hoskins WJ, Brady MF et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996; 334: 1-6.
-
(1996)
N Engl J Med
, vol.334
, pp. 1-6
-
-
McGuire, W.P.1
Hoskins, W.J.2
Brady, M.F.3
-
4
-
-
0000264166
-
Updated analysis shows a highly significant improvement in overall survival (OS) for cisplatin-paclitaxel as first line treatment of advanced ovarian cancer: Mature results of the EORTC-GCCG, NOCOVA,NCIC and Scottish Intergroup trial
-
abstract
-
Stuart G, Bertelsen K, Mangioni C et al. Updated analysis shows a highly significant improvement in overall survival (OS) for cisplatin-paclitaxel as first line treatment of advanced ovarian cancer: Mature results of the EORTC-GCCG, NOCOVA,NCIC and Scottish Intergroup trial. Proc Am Soc Clin Oncol 1998; 17: 361a (abstract).
-
(1998)
Proc Am Soc Clin Oncol
, vol.17
-
-
Stuart, G.1
Bertelsen, K.2
Mangioni, C.3
-
6
-
-
0030920691
-
How many more nails to seal the coffin of dose intensity?
-
McGuire W. How many more nails to seal the coffin of dose intensity? Ann Oncol 1997; 8: 311-3.
-
(1997)
Ann Oncol
, vol.8
, pp. 311-313
-
-
McGuire, W.1
-
7
-
-
0000599076
-
High dose chemotherapy with autologous bone marrow support for the treatment of epithelial ovarian cancer in Cancer of the Ovary
-
Hoskins WJ, Markman M, eds. New York: Raven Press
-
Shpall E, Stemmer S, Bearman S et al. High dose chemotherapy with autologous bone marrow support for the treatment of epithelial ovarian cancer in Cancer of the Ovary. In: Hoskins WJ, Markman M, eds. Cancer of the Ovary. New York: Raven Press, 1993: 327-38.
-
(1993)
Cancer of the Ovary
, pp. 327-338
-
-
Shpall, E.1
Stemmer, S.2
Bearman, S.3
-
8
-
-
0030901014
-
High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: A multivariate analysis of survival for 100 consecutively treated patients
-
Stiff PJ, Bayer R, Kerger C et al. High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patients. J Clin Oncol 1997; 15: 1309-17.
-
(1997)
J Clin Oncol
, vol.15
, pp. 1309-1317
-
-
Stiff, P.J.1
Bayer, R.2
Kerger, C.3
-
9
-
-
17344382260
-
High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: Long-term results
-
Legros M, Dauplat J, Fleury J et al. High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term results. J Clin Oncol 1997; 15: 1302-8.
-
(1997)
J Clin Oncol
, vol.15
, pp. 1302-1308
-
-
Legros, M.1
Dauplat, J.2
Fleury, J.3
-
10
-
-
0002768303
-
High Dose Chemotherapy in Ovarian Cancer: An Analysis of the Experience of the European Group for Blood and Marrow Transplant (EBMT) over 7 Years
-
abstract
-
Ledermann JA, Herd R, Maraninchi D et al. High Dose Chemotherapy in Ovarian Cancer: an Analysis of the Experience of the European Group for Blood and Marrow Transplant (EBMT) over 7 Years. Proc Am Soc Clin Oncol 1999; 18: 360a (abstract).
-
(1999)
Proc Am Soc Clin Oncol
, vol.18
-
-
Ledermann, J.A.1
Herd, R.2
Maraninchi, D.3
-
11
-
-
0029116891
-
High-dose chemotherapy with haematopoetic rescue as primary treatment for metastatic breast cancer: A randomzed trial
-
Bezwoda WR, Seymour L, Dansey RD. High-dose chemotherapy with haematopoetic rescue as primary treatment for metastatic breast cancer: a randomzed trial. J Clin Oncol 1995; 13: 2483-9.
-
(1995)
J Clin Oncol
, vol.13
, pp. 2483-2489
-
-
Bezwoda, W.R.1
Seymour, L.2
Dansey, R.D.3
-
12
-
-
0003344884
-
Randomised, controlled trial of high dose chemotherapy (HD-CNVP) versus standard dose (CAF) chemotherapy for high risk, surgically treated, primary breast cancer
-
abstract
-
Bezwoda W. Randomised, controlled trial of high dose chemotherapy (HD-CNVP) versus standard dose (CAF) chemotherapy for high risk, surgically treated, primary breast cancer. Proc Am Soc Clin Oncol 1999; 18: 2a (abstract).
-
(1999)
Proc Am Soc Clin Oncol
, vol.18
-
-
Bezwoda, W.1
-
13
-
-
0029053113
-
Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/ cyclophosphamide courses
-
Fennelly D, Schneider J, Spriggs D et al. Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/ cyclophosphamide courses. J Clin Oncol 1995; 13: 1160-6.
-
(1995)
J Clin Oncol
, vol.13
, pp. 1160-1166
-
-
Fennelly, D.1
Schneider, J.2
Spriggs, D.3
-
14
-
-
0032945999
-
Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: A phase I/II study in advanced ovarian cancer
-
Wandt H, Birkmann J, Denzel T et al. Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancer. Bone Marrow Transplant 1999; 23: 763-70.
-
(1999)
Bone Marrow Transplant
, vol.23
, pp. 763-770
-
-
Wandt, H.1
Birkmann, J.2
Denzel, T.3
|